» Articles » PMID: 26597987

The Chromosome-Encoded Hypothetical Protein TC0668 Is an Upper Genital Tract Pathogenicity Factor of Chlamydia Muridarum

Overview
Journal Infect Immun
Date 2015 Nov 25
PMID 26597987
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

We previously associated a missense mutation of the tc0668 gene of serial in vitro-passaged Chlamydia muridarum, a murine model of human urogenital C. trachomatis, with severely attenuated disease development in the upper genital tract of female mice. Since these mutants also contained a TC0237 Q117E missense mutation that enhances their in vitro infectivity, an effort was made here to isolate and characterize a tc0668 single mutant to determine its individual contribution to urogenital pathogenicity. Detailed genetic analysis of C. muridarum passages revealed a truncated variant with a G216* nonsense mutation of the 408-amino-acid TC0668 protein that does not produce a detectable product. Intracellular growth and infectivity of C. muridarum in vitro remain unaffected in the absence of TC0668. Intravaginal inoculation of the TC0668 null mutant into C3H/HeJ mice results in a typical course of lower genital tract infection but, unlike a pathogenic isogenic control, is unable to elicit significant chronic inflammation of the oviduct and fails to induce hydrosalpinx. Thus, TC0668 is demonstrated as an important chromosome-encoded urogenital pathogenicity factor of C. muridarum and the first with these characteristics to be discovered for a Chlamydia pathogen.

Citing Articles

Development and Validation of Mouse Models for Studying Genital Tract Infection Pathogenesis.

Wang Y, Han Z, Wang L, Sun X, Tian Q, Zhang T Bio Protoc. 2025; 15(3):e5181.

PMID: 39959295 PMC: 11825293. DOI: 10.21769/BioProtoc.5181.


Advances in vaccine development for Chlamydia trachomatis.

Poston T Pathog Dis. 2024; 82.

PMID: 39043447 PMC: 11338180. DOI: 10.1093/femspd/ftae017.


Diverse animal models for infections: unraveling pathogenesis through the genital and gastrointestinal tracts.

Tian Q, Zhang T, Shu C, Han Z, Huang Y, Wan J Front Microbiol. 2024; 15:1386343.

PMID: 38605708 PMC: 11007077. DOI: 10.3389/fmicb.2024.1386343.


Preclinical screen for protection efficacy of chlamydial antigens that are immunogenic in humans.

Lu C, Wang J, Zhong G Infect Immun. 2023; 91(11):e0034923.

PMID: 37889004 PMC: 10652899. DOI: 10.1128/iai.00349-23.


IL-23 receptor signaling licenses group 3-like innate lymphoid cells to restrict a live-attenuated oral Chlamydia vaccine in the gut.

He Y, Wang Y, He R, Abdelsalam A, Zhong G Infect Immun. 2023; 91(11):e0037123.

PMID: 37850749 PMC: 10652955. DOI: 10.1128/iai.00371-23.


References
1.
Campbell J, Huang Y, Liu Y, Schenken R, Arulanandam B, Zhong G . Bioluminescence imaging of Chlamydia muridarum ascending infection in mice. PLoS One. 2014; 9(7):e101634. PMC: 4077820. DOI: 10.1371/journal.pone.0101634. View

2.
Russell M, Darville T, Chandra-Kuntal K, Smith B, Andrews Jr C, OConnell C . Infectivity acts as in vivo selection for maintenance of the chlamydial cryptic plasmid. Infect Immun. 2010; 79(1):98-107. PMC: 3019909. DOI: 10.1128/IAI.01105-10. View

3.
Liu X, Afrane M, Clemmer D, Zhong G, Nelson D . Identification of Chlamydia trachomatis outer membrane complex proteins by differential proteomics. J Bacteriol. 2010; 192(11):2852-60. PMC: 2876478. DOI: 10.1128/JB.01628-09. View

4.
Shah A, Schripsema J, Imtiaz M, Sigar I, Kasimos J, Matos P . Histopathologic changes related to fibrotic oviduct occlusion after genital tract infection of mice with Chlamydia muridarum. Sex Transm Dis. 2004; 32(1):49-56. DOI: 10.1097/01.olq.0000148299.14513.11. View

5.
Maxion H, Liu W, Chang M, Kelly K . The infecting dose of Chlamydia muridarum modulates the innate immune response and ascending infection. Infect Immun. 2004; 72(11):6330-40. PMC: 523032. DOI: 10.1128/IAI.72.11.6330-6340.2004. View